Klox Technologies an
Klox Technologies announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma
July 02, 2018 08:00 ET | Klox Technologies, Inc.
DUBLIN, Ireland, July 02, 2018 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘KTI’) has announced they have completed a pivotal study of Phovia for the...
Preliminary results
Preliminary results for Phovia™ in the treatment of Canine Chronic Otitis to be presented at ECVS scientific meeting
March 27, 2017 02:30 ET | Klox Technologies, Inc.
DUBLIN, Ireland, March 27, 2017 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘Klox’) has announced that the European College of Veterinary Surgeons (‘ECVS’)...
Klox Technologies an
Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatology
March 06, 2017 10:46 ET | Klox Technologies, Inc.
LAVAL, Quebec and BALLERUP, Denmark, March 06, 2017 (GLOBE NEWSWIRE) -- Klox Technologies Inc. (‘Klox’) and LEO Pharma A/S (‘LEO Pharma’) to establish a jointly owned company to further develop and...
Photobiomodulation Ranks Among "Hot Topics" in Laser Medicine WAUSAU, Wis., March 23, 2013 (GLOBE NEWSWIRE) -- "Hot Topics" at Laser 2013 will include a Photobiomodulation Session on Friday, April 5 and Saturday, April 6 as part of the 33rd Annual Conference of...